Biomarkers Towards New Era of Therapeutics for Metastatic Renal Cell Carcinoma
With the improved knowledge of molecular oncology and the introduction of targeted therapies as well as immunotherapies, there has been significant progress in the treatment of patients with metastatic renal cell carcinoma (mRCC). At present, treatment decisions are still made mainly based on clinic...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publishing
2020-07-01
|
| Reeks: | Kidney Cancer |
| Online toegang: | https://doi.org/10.3233/KCA-190067 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|